Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists on the Move

Ann-Marie Lindstrom  |  Issue: May 2015  |  May 15, 2015

Dr. Glimcher spoke to The Rheumatologist about research on Schnurri-3 (SHN3) at the Cornell-affiliated Hospital of Special Surgery (HSS). She and her research team at Harvard had discovered back in 2005 that mice without the SHN3 gene grew new bone. Now HSS researchers are investigating how SHN3 functions in bone formation. Counteracting the bony erosion that occurs in rheumatoid arthritis is just one of the possible outcomes of understanding the SHN3 function. Other applications of the knowledge could be preventing/treating osteoporosis and dealing with bone pain connected to cancer.

Exemplifying the range of her duties at Weill Cornell, and perhaps drawing on her experience as a mother of three children, Dr. Glimcher recently announced the Family Friendly Postdoctoral Initiative. The goal of the initiative is to annually provide about 10 grants of $50,000 for one or two years to outstanding postdoctoral researchers “who are primary caregivers for an infant or child.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Ann-Marie Lindstrom is an independent writer and editor based in the Tucson, Ariz., area.

Page: 1 2 3 | Single Page
Share: 

Filed under:Professional TopicsProfiles Tagged with:appointmentsAwardsCareerrheumatologist

Related Articles
    futuristman / shutterstock.com

    Fulbright Scholar Researches Physical Activity in Swedish Children with Juvenile Idiopathic Arthritis

    October 18, 2017

    A stroll through downtown Stockholm presents a quintessential picture of an active community, with most people biking or walking as their preferred mode of travel. Yet children in Sweden who live with juvenile idiopathic arthritis (JIA)—currently estimated at around 64 of every 100,000—don’t always engage in this active lifestyle.1 Maura Daly Iversen, PT, DPT, SD,…

    2015 ACR/ARHP Annual Meeting: Therapies that Target Schnurri-3 Hold Promise for Osteoporosis

    April 14, 2016

    SAN FRANCISCO—The discovery of a promising new target for the treatment of osteoporosis has a beginning to the story that, when it comes to scientific breakthroughs, rings familiar: It started with a disappointment. Researchers in the lab of Laurie H. Glimcher, MD, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College—were in search…

    The 2020 ARP Merit Awards & ACR Distinguished Fellows

    December 14, 2020

    During ACR Convergence 2020 in early November, the ACR and ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards and the ACR’s Distinguished Fellows. In addition, we bring you the first ever…

    Tech Talk: Smartphone Apps, Online Games May Encourage Healthy Behaviors in Rheumatology Patients

    February 1, 2014

    Customized text messages and virtual reality technology can help health professionals prompt patients to take medications and get exercise

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences